Showing 42,321 - 42,340 results of 113,932 for search '(( 5 ((a decrease) OR (mean decrease)) ) OR ( a ((fold decrease) OR (point decrease)) ))', query time: 1.23s Refine Results
  1. 42321

    A Spironolactone−Saccharin 1:1 Cocrystal Hemihydrate by Noriyuki Takata (2131315)

    Published 2010
    “…However, the concentration decreased after reaching the maximum and the cocrystal hydrate converted to a previously unreported spironolactone 1/3 hydrate which was ∼0.8 times less soluble than spironolactone form II.…”
  2. 42322

    Patient’s description. by Jean-Philippe Chippaux (790696)

    Published 2023
    “…Among these patients, cytotoxic symptoms were observed in 336 (94.4%) participants, coagulation disorders in 234 (65.7%) participants and neurotoxicity in 23 (6.5%) participants. Two hours after the first administration of antivenom, we observed a decrease in coagulation disorders or neurotoxicity in 75.2% and 39.1% of patients, respectively. …”
  3. 42323

    Deceased patients. by Jean-Philippe Chippaux (790696)

    Published 2023
    “…Among these patients, cytotoxic symptoms were observed in 336 (94.4%) participants, coagulation disorders in 234 (65.7%) participants and neurotoxicity in 23 (6.5%) participants. Two hours after the first administration of antivenom, we observed a decrease in coagulation disorders or neurotoxicity in 75.2% and 39.1% of patients, respectively. …”
  4. 42324

    Participant characteristics. by Ronald Kusolo (13200268)

    Published 2025
    “…The risk factor prevalences that decreased significantly were: inadequate physical activity from 5.0% in 2014 to 3.6% in 2023 (p=0.003), and current smoke tobacco use from 9.6% in 2014, to 8.3% in 2023 (p= 0.046). …”
  5. 42325
  6. 42326
  7. 42327
  8. 42328

    A dynamin inhibitory peptide blocks intrinsic plasticity. by Sung-Cherl Jung (261358)

    Published 2009
    “…<p>A. Pooled synaptic potentiation for experiments using an intracellular dynamin inhibitory peptide (DYN) and control (scrambled DYN, sDYN). …”
  9. 42329

    Uganda 2023 NCD risk factor STEPS survey data. by Ronald Kusolo (13200268)

    Published 2025
    “…The risk factor prevalences that decreased significantly were: inadequate physical activity from 5.0% in 2014 to 3.6% in 2023 (p=0.003), and current smoke tobacco use from 9.6% in 2014, to 8.3% in 2023 (p= 0.046). …”
  10. 42330

    Uganda 2014 NCD risk factor STEPS survey data. by Ronald Kusolo (13200268)

    Published 2025
    “…The risk factor prevalences that decreased significantly were: inadequate physical activity from 5.0% in 2014 to 3.6% in 2023 (p=0.003), and current smoke tobacco use from 9.6% in 2014, to 8.3% in 2023 (p= 0.046). …”
  11. 42331

    Efficacy of a connected insulin pen cap in people with non-controlled type 1 diabetes mellitus: a multicenter randomized clinical trial by Fernando Gomez‐Peralta (12159833)

    Published 2022
    “…The increase in TIR was higher in the active vs. the masked group (+5.2% vs. -0.8%; p=0.016). The active group showed a higher reduction in mean glucose, glucose management indicator (GMI), time above range (TAR), and high blood glucose index (HBGI). …”
  12. 42332

    Identification of TXNIP as a regulator of lactic acidosis response. by Julia Ling-Yu Chen (242650)

    Published 2010
    “…<p>(A) The level of TXNIP proteins treated with control or siRNAs against TXNIP under control or lactic acidosis conditions. …”
  13. 42333

    Myocardial Bridge as a Cause of Exertional Chest Pain by Camilo Velasquez (10204347)

    Published 2021
    “…Surgical unroofing of hemodynamically significant left anterior descending myocardial bridges. <a href="https://doi.org/10.1016/j.athoracsur.2016.08.035"><em>Ann Thorac Surg</em>. 2017;103(5):1443-1450</a>.…”
  14. 42334

    LC MS/MS proteomic analysis of mouse proteins in vaginal brush samples that are down-regulated in response to treatment with N9 (open, black circles) or BZK (closed squares). by Scott Fields (12226)

    Published 2014
    “…<p>Shown are proteins that were decreased relative to vehicle controls. The following proteins are shown: peptidoglycan recognition protein 1 (PGLYRP-1), mucin 5 subtype B (mucin 5B), destrin, and carbonyl reductase 3 (CAR3). …”
  15. 42335

    Nonstoichiometric Control of Tunnel-Filling Order, Thermal Expansion, and Dielectric Relaxation in Tetragonal Tungsten Bronzes Ba<sub>0.5–<i>x</i></sub>TaO<sub>3–<i>x</i></sub> by Fengjuan Pan (1527526)

    Published 2015
    “…In contrast with stoichiometric Ba<sub>6</sub>GaTa<sub>9</sub>O<sub>30</sub>, which shows linear thermal expansion of the cell parameters and monotonic decrease of permittivity with temperature within 100–800 K, these TTB superstructures and slightly nonstoichiometric simple TTB Ba<sub>0.4</sub>TaO<sub>2.9</sub> display abnormally broad and frequency-dependent extrinsic dielectric relaxations in 10<sup>3</sup>–10<sup>5</sup> Hz above room temperature, a linear deviation of the <i>c</i>-axis thermal expansion around 600 K, and high dielectric permittivity ∼60–95 at 1 MHz at room temperature.…”
  16. 42336

    Developmental changes in connectivity strength are not a function of distance. by Scott Marek (841529)

    Published 2016
    “…(B) Each point represents a pairwise relationship between two regions of interest. …”
  17. 42337
  18. 42338

    DNA Methylation as a Biomarker for Cardiovascular Disease Risk by Myungjin Kim (60778)

    Published 2010
    “…<div><h3>Background</h3><p>Elevated serum homocysteine is associated with an increased risk of cardiovascular disease (CVD). This may reflect a reduced systemic remethylation capacity, which would be expected to cause decreased genomic DNA methylation in peripheral blood leukocytes (PBL).…”
  19. 42339

    Number of IPA vials used during the ESAA study. by Jean-Philippe Chippaux (790696)

    Published 2023
    “…Among these patients, cytotoxic symptoms were observed in 336 (94.4%) participants, coagulation disorders in 234 (65.7%) participants and neurotoxicity in 23 (6.5%) participants. Two hours after the first administration of antivenom, we observed a decrease in coagulation disorders or neurotoxicity in 75.2% and 39.1% of patients, respectively. …”
  20. 42340